Clark G - Search Results

1

A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.

Lebowitz PF, Eng-Wong J, Widemann BC, Balis FM, Jayaprakash N, Chow C, Clark G, Gantz SB, Venzon D, Zujewski J. Lebowitz PF, et al. Among authors: clark g. Clin Cancer Res. 2005 Feb 1;11(3):1247-52. Clin Cancer Res. 2005. PMID: 15709195 Clinical Trial.

2

Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.

Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS. Hartsough MT, et al. Among authors: clark g. Cancer Res. 2001 Mar 1;61(5):2320-7. Cancer Res. 2001. PMID: 11280805

3

Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients.

Jones S, Clark G, Koleszar S, Ethington G, Mennel R, Paulson S, Brooks B, Kerr R, Denham C, Savin M, White C, Blum J, Kirby R, Stone M, Pippen J, Kitchens L, George T, Cooper B, Peters G, Knox S, Grant M, Cheek H, Jones R, Kuhn J, Lieberman Z, Savino D, Rietz C. Jones S, et al. Among authors: clark g. Clin Breast Cancer. 2001 Jan;1(4):310-4; discussion 315-7. doi: 10.3816/CBC.2001.n.005. Clin Breast Cancer. 2001. PMID: 11899353

4

Phase I clinical and pharmacokinetic trial of flavone acetic acid.

Havlin KA, Kuhn JG, Craig JB, Boldt DH, Weiss GR, Koeller J, Harman G, Schwartz R, Clark GN, Von Hoff DD. Havlin KA, et al. Among authors: clark gn. J Natl Cancer Inst. 1991 Jan 16;83(2):124-8. doi: 10.1093/jnci/83.2.124. J Natl Cancer Inst. 1991. PMID: 1703237 Clinical Trial.

5

Direct cloning of human breast cancer in soft agar culture.

Sandbach J, Von Hoff DD, Clark G, Cruz AB Jr, Obrien M. Sandbach J, et al. Among authors: clark g. Cancer. 1982 Oct 1;50(7):1315-21. doi: 10.1002/1097-0142(19821001)50:7<1315::aid-cncr2820500717>3.0.co;2-7. Cancer. 1982. PMID: 7049348

6

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).

Von Hoff DD, Myers JW, Kuhn J, Sandbach JF, Pocelinko R, Clark G, Coltman CA Jr. Von Hoff DD, et al. Among authors: clark g. Cancer Res. 1981 Aug;41(8):3118-21. Cancer Res. 1981. PMID: 6265075

7

A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days.

Wall JG, Burris HA 3rd, Von Hoff DD, Rodriguez G, Kneuper-Hall R, Shaffer D, O'Rourke T, Brown T, Weiss G, Clark G, et al. Wall JG, et al. Among authors: clark g. Anticancer Drugs. 1992 Aug;3(4):337-45. doi: 10.1097/00001813-199208000-00004. Anticancer Drugs. 1992. PMID: 1330081 Clinical Trial.

8

Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units.

Raymond E, Hanauske A, Faivre S, Izbicka E, Clark G, Rowinsky EK, Von Hoff DD. Raymond E, et al. Among authors: clark g. Anticancer Drugs. 1997 Apr;8(4):379-85. doi: 10.1097/00001813-199704000-00011. Anticancer Drugs. 1997. PMID: 9180392

9

Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite.

Hutton JJ, Von Hoff DD, Kuhn J, Phillips J, Hersh M, Clark G. Hutton JJ, et al. Among authors: clark g. Cancer Res. 1984 Sep;44(9):4183-6. Cancer Res. 1984. PMID: 6204752

10

Androgen priming and cytotoxic chemotherapy in advanced prostatic cancer.

Suarez AJ, Lamm DL, Radwin HM, Sarosdy M, Clark G, Osborne CK. Suarez AJ, et al. Among authors: clark g. Cancer Chemother Pharmacol. 1982;8(3):261-5. doi: 10.1007/BF00254047. Cancer Chemother Pharmacol. 1982. PMID: 7127658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,011 results

Search Page

Filters